Detalhe da pesquisa
1.
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Lancet Oncol
; 24(8): e344-e354, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37541280
2.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 23(2): 279-291, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35033226
3.
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
Cancer
; 125(16): 2732-2746, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31017664
4.
Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.
J Neurooncol
; 134(3): 551-557, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28560665
5.
Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer.
Cancer Rep (Hoboken)
; 5(12): e1553, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34533293
6.
The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation.
Radiat Res
; 198(6): 625-631, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35976726
7.
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
J Immunother Cancer
; 9(4)2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33827904
8.
SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme.
Radiat Res
; 195(6): 549-560, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33826739
9.
Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care.
JNCI Cancer Spectr
; 5(4)2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34350377
10.
Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies.
J Natl Cancer Inst
; 113(6): 665-679, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33351071
11.
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.
J Natl Cancer Inst
; 113(10): 1285-1298, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33792717
12.
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
Clin Cancer Res
; 27(9): 2470-2480, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33568343
13.
Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells.
Pancreatology
; 10(5): 565-79, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20980775
14.
Novel Radiation Therapy Paradigms and Immunomodulation: Heresies and Hope.
Semin Radiat Oncol
; 30(2): 194-200, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32381299
15.
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group.
Radiat Res
; 194(6): 665-677, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33348375
16.
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Radiat Res
; 194(5): 452-464, 2020 11 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33045077
17.
Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 107(4): 766-778, 2020 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32298811
18.
Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
Mol Cancer Res
; 6(11): 1742-54, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19010821
19.
Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells.
Mol Cancer Res
; 6(1): 89-98, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-18234965
20.
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
Cancer Res
; 79(17): 4326-4330, 2019 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31481419